Drug Side Effects
Search
TREATMENT RELATED SECONDARY MALIGNANCY
TREATMENT RELATED SECONDARY MALIGNANCY
was reported 203 times
These drug classes are most commonly taken by patients reporting TREATMENT RELATED SECONDARY MALIGNANCY:
#
Drug
Count
0
Alkylating Drug [EPC]
94
1
Folate Analog Metabolic Inhibitor [EPC]
52
2
Nucleoside Metabolic Inhibitor [EPC]
48
3
Topoisomerase Inhibitor [EPC]
45
4
Platinum-based Drug [EPC]
38
5
Corticosteroid [EPC]
33
6
Microtubule Inhibitor [EPC]
14
7
Actinomycin [EPC]
13
8
CD20-directed Cytolytic Antibody [EPC]
10
9
Antimetabolite [EPC]
8
10
Thalidomide Analog [EPC]
5
11
Leukocyte Growth Factor [EPC]
4
12
Purine Antimetabolite [EPC]
4
13
Retinoid [EPC]
4
14
Vitamin C [EPC]
4
15
Azole Antifungal [EPC]
3
16
Calcineurin Inhibitor Immunosuppressant [EPC]
3
17
Nonsteroidal Anti-inflammatory Drug [EPC]
3
18
Proteasome Inhibitor [EPC]
3
19
Vitamin B12 [EPC]
3
20
Vitamin D [EPC]
3
21
Fluoroquinolone Antibacterial [EPC]
2
22
HER2/neu Receptor Antagonist [EPC]
2
23
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
24
Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
25
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
26
Kinase Inhibitor [EPC]
2
27
Tumor Necrosis Factor Blocker [EPC]
2
28
Vascular Endothelial Growth Factor Inhibitor [EPC]
2
29
Aminosalicylate [EPC]
1
30
Angiotensin 2 Receptor Blocker [EPC]
1
31
Aromatase Inhibitor [EPC]
1
32
Benzodiazepine [EPC]
1
33
CD33-directed Immunoconjugate [EPC]
1
34
CD52-directed Cytolytic Antibody [EPC]
1
35
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
1
36
Erythropoiesis-stimulating Agent [EPC]
1
37
Estrogen [EPC]
1
38
Histamine-2 Receptor Antagonist [EPC]
1
39
Nicotinic Acid [EPC]
1
40
Platelet Aggregation Inhibitor [EPC]
1
41
Proton Pump Inhibitor [EPC]
1
42
Sulfonamide Antimicrobial [EPC]
1
43
Sulfonylurea [EPC]
1
44
Xanthine Oxidase Inhibitor [EPC]
1
45
beta-Adrenergic Blocker [EPC]
1
46
mTOR Inhibitor Immunosuppressant [EPC]
1